Antimicrobianos Orgânicos

Nanoclean 80: Antimicrobiano orgânico desenvolvido dentro do padrão ANVISA elimina bactérias, vírus, bolores e leveduras. Elimina microorganismos prejudiciais as pessoas. Nanoclean 80 é um masterbatch antibacteriano potente, econômico e eficiente, aditivado com as resinas durante a fabricação dos produtos (duráveis e descartáveis) tendo uma eficiência por toda a vida útil do produto. Nanoclean 80 elimina os vírus envelopados (gripe, influenza, H1N1, gripe aviária, H1N5, gripe suína, H3N2v, hepatite A, hepatite B, hepatite C, HIV etc.). Produtos aditivados agregam segurança em hospitais, transporte coletivo, escolas, aeroportos, repartições públicas, restaurantes e até mesmo na sua residência. Antimicrobial Organic eficiente. Antibacterial Organic potente. Eficient Protection. Produtos aditivados com Nanoclean 80 agregam as funções antibacteriana e bacteriostática de forma definitiva.Potente redutor de Infecção Hospitalar e Contaminação Cruzada. Nanoclean é um produto eficiente e econômico, Nanoclean é o produto mais competitivo do mercado. Marca registrada e Tecnologia patenteada pela Provida.

 

Leia mais...
Você está em: Home Bactérias Causas e Efeitos H1N1

H1N1

Influenza H1N1, publicado no ICT (Infection Control Today), em Inglês.

Provida Provendo Soluções Preservando Vidas. Eficiente Contra Bactérias, Vírus e Fungos. Prevenção deveria ser Obrigação!

During the April-July 2009 outbreak of H1N1/2009 in scotland the West of Scotland Specialist Virology Centre (WoSSVC) in Glasgow tested more than 16 000 clinical samples for H1N1/2009. Most were from patients clinically diagnosed with H1N1/2009. Out of these, 9 percent were positive. Rory N Gunson and William F Carman of Gartnavel General Hospital in Glasgow, Scotland, sought to determine what respiratory pathogens were misdiagnosed as cases of H1N1/2009 during this time.

The researchers examined the results from 3,247 samples which were sent to the laboratory during April-July 2009. All were from patients clinically diagnosed as having H1N1/2009 (based on accepted criteria) and all were given a full respiratory screen using real time reverse transcriptase polymerase chain reaction (rtRT-PCR) assays.

 

In total, respiratory pathogens were detected in 27.9 percent (95% confidence interval, 26.3-29.5%) of the samples submitted. Numerous pathogens were detected, the most common of which were rhinovirus (8.9 percent (95% confidence interval, 7.9-9.9%)), parainfluenza 1 (1.9% (95% confidence interval, 1.4-2.4%)) and 3 (4.1% (95% confidence interval, 3.3-4.9%)), and adenovirus ((3.5 percent (95% confidence interval, 2.9-4.2%)).

 

This study highlights the problems of using a clinical algorithm to detect H1N1/2009. Clinicians frequently misdiagnosed common respiratory pathogens as H1N1/2009 during the spring/summer outbreak in Scotland. The researchers say that many undesirable consequences would have resulted, relating to treatment, infection control, and public health surveillance. Their research was published in BMC Infectious Diseases.

 

Reference: Gunson RN and Carman WF. During the summer 2009 outbreak of "swine flu" in Scotland what respiratory pathogens were diagnosed as H1N1/2009? BMC Infectious Diseases 2011, 11:192doi:10.1186/1471-2334-11-192

 

Contatos

Pomerode/SC
+55 (047) 9983-7850 ou +55 (047) 3380-1857

Todos os Direitos Reservados ® Provida 2023